Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Acute paediatric mastoiditis in the UK before and during the COVID-19 pandemic: A national observational study
Clinical Otolaryngology, Volume 47, No. 1, Year 2022
Notification
URL copied to clipboard!
Description
Objectives: To explore the impact of COVID-19 on the management and outcomes of acute paediatric mastoiditis across the UK. Design: National retrospective and prospective audit. Setting: 48 UK secondary care ENT departments. Participants: Consecutive children aged 18 years or under, referred to ENT with a clinical diagnosis of mastoiditis. Main outcome measures: Cases were divided into Period 1 (01/11/19-15/03/20), before the UK population were instructed to reduce social contact, and Period 2 (16/03/20-30/04/21), following this. Periods 1 and 2 were compared for population variables, management and outcomes. Secondary analyses compared outcomes by primary treatment (medical/needle aspiration/surgical). Results: 286 cases met criteria (median 4 per site, range 0–24). 9.4 cases were recorded per week in period 1 versus 2.0 in period 2, with no winter increase in cases in December 2020-Febraury 2021. Patient age differed between periods 1 and 2 (3.2 vs 4.7 years respectively, p < 0.001). 85% of children in period 2 were tested for COVID-19 with a single positive test. In period, 2 cases associated with P. aeruginosa significantly increased. 48.6% of children were scanned in period 1 vs 41.1% in period 2. Surgical management was used more frequently in period 1 (43.0% vs 24.3%, p = 0.001). Treatment success was high, with failure of initial management in 6.3%, and 30-day re-admission for recurrence in 2.1%. The adverse event rate (15.7% overall) did not vary by treatment modality or between periods 1& 2. Conclusion: The COVID-19 pandemic led to a significant change in the presentation and case mix of acute paediatric mastoiditis in the UK. © 2021 John Wiley & Sons Ltd
Authors & Co-Authors
Nichani, Jaya R.
United Kingdom, Manchester
Royal Manchester Children's Hospital
Khwaja, Sadie
United Kingdom, Manchester
Manchester University Nhs Foundation Trust
Bruce, Iain Alexander
United Kingdom, Manchester
Health Innovation Manchester
Rea, Peter A.
United Kingdom, Leicester
Leicester Royal Infirmary
Whitehall, Emma
Unknown Affiliation
Sethukumar, Priya
Unknown Affiliation
Jama, Guled M.
Unknown Affiliation
Forde, Cillian T.
Unknown Affiliation
Krishnan, Madhankumar
Unknown Affiliation
Takwoingi, Yohanna M.
Unknown Affiliation
Strachan, David R.
Unknown Affiliation
Iyer, Arunachalam
Unknown Affiliation
Hall, Andrew Christopher
Unknown Affiliation
Allam, Ahmed A.
Unknown Affiliation
Statistics
Citations: 5
Authors: 14
Affiliations: 7
Identifiers
Doi:
10.1111/coa.13869
ISSN:
17494478
Research Areas
Covid
Health System And Policy
Maternal And Child Health
Study Design
Cross Sectional Study
Cohort Study